FDA delays key advisory committee assembly on OTC contraception

“Within the wake of the acute Supreme Court docket choice to overturn Roe v. Wade, the power to determine if and when to turn out to be pregnant has by no means been extra necessary,” Home Oversight Chairwoman Carolyn B. Maloney, D-N.Y., stated in an announcement.

Democrats have pressured the administration to behave on increasing and defending the correct to contraception for the reason that Dobbs v. Jackson Girls’s Well being Group ruling. The 1973 Roe v. Wade ruling cited Griswold v. Connecticut, a landmark 1965 privateness choice associated to the correct for married {couples} to make use of contraception.

In July, the Home handed its contraception rights invoice by a vote of 228-195, with eight Republicans becoming a member of 220 Democrats. 

Advocates for contraception are likewise upping the strain. Ibis Reproductive Well being, which runs the “Free the Capsule” marketing campaign, stated it was “pissed off and deeply disenchanted” within the FDA’s delay.

“Rising entry to contraception by eradicating the prescription requirement is a public well being precedence, and now greater than ever, we have to improve entry to the contraception individuals need and want,” the group stated in an announcement.  

See also  US, Taiwan grapple with key variations in debate over deterring China